Dr. Marisa Mizus

Contact: (410) 583-2604  |  Assistant: Amy Jones
Specialties:  Internal Medicine, Rheumatology
Medical School: New York University School of Medicine
Other Graduate: Masters of Science in Translational Research from Perelman School of Medicine at the University of Pennsylvania
Undergraduate School: Washington University in St. Louis
Certifications: Internal Medicine, Rheumatology
Residency: Hospital of the University of Pennsylvania
Fellowship: Research Fellowship in Vascular Medicine at the Hospital of the University of Pennsylvania 
Fellowship in Rheumatology at Johns Hopkins University School of Medicine, Johns Hopkins Hospital
Faculty Position: Department of Medicine at George Washington University SOM

 
Professional Highlights: 
  1. Leadership board of the Maryland chapter of the Arthritis Foundation
  2. Gordon Memorial Fund Award, Johns Hopkins Division of Rheumatology
  3. Institute for Translational Medicine and Therapeutics Scholarship, Perelman School of Medicine at the University of Pennsylvania
  4. The Lupus Foundation of America Gina Finzi Memorial Student Summer Fellowship Grant 
  5. Clinical Preceptorship in Rheumatology, American College of Rheumatology Research and Education Fund  

Dr. Mizus earned a Bachelor of Arts in Philosophy from Washington University in St. Louis and a Medical Degree from New York University School of Medicine. She completed her Internal Medicine Residency at the Hospital of the University of Pennsylvania. She subsequently went on to complete a Research Fellowship in Vascular Medicine at the Hospital of the University of Pennsylvania while simultaneously earning a Masters of Science in Translational Research from Perelman School of Medicine at the University of Pennsylvania. She completed a Fellowship in Rheumatology at the Johns Hopkins School of Medicine in 2020. 

During her Rheumatology Fellowship, she investigated cardiovascular complications of autoimmune diseases with a special focus on lupus, idiopathic inflammatory myopathies, and spondyloarthropathies. 

Prior to joining Falls Medical Specialists, she practiced in the Division of Rheumatology at Sinai Hospital in Baltimore, MD. 

Dr. Mizus is board certified in Internal Medicine and Rheumatology. Throughout her medical career, she has demonstrated a passion for patient care, informed by her clinical and research experiences. 

Dr. Mizus maintains an ongoing collaboration with the Johns Hopkins Division of Rheumatology, contributing to a range of research initiatives while mentoring and teaching aspiring medical professionals. She is actively involved with the Arthritis Foundation of Maryland and the Lupus Foundation, and is a proud member of the American College of Rheumatology. Recently, Dr. Mizus has taken on new leadership roles as Co-President of the Maryland Society of Rheumatic Diseases and as the Maryland Chapter Leader of the Association of Women in Rheumatology.

Research & Publications:
  • Mizus M. When Clopidogrel Fails. Clinical Correlations.March 10, 2010 < http://www.clinicalcorrelations.org/?p=2365>. 
  • Fields AV, Mizus MC, Forfia PR. Premature onset aortic valve stenosis may be another end-organ complication of limited scleroderma. American Journal of Respiratory and Critical Care Medicine. 2012 May; Vol 185. pp. A1893. 
  • CN, M., Mizus, M., JW, W., Goldberg, L., Jessup, M., & CA, U. (2016). Brain-type natriuretic peptide and amino-terminal pro–brain-type natriuretic peptide discharge thresholds for acute decompensated heart failure: A systematic review. Annals of Internal Medicine. 2017. Retrieved from http://dx.doi.org/10.7326/M16-1468

 

 

 
  • Mizus M, Li J, Goldman D, Petri MA. Autoantibody clustering of lupus-associated pulmonary hypertension. Lupus Sci Med. 2019;6:e000356.  
  • Mizus M, Li J, Goldman D, Petri M. Defining the SLE-Associated Pulmonary Arterial Hypertension Phenotype [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/defining-the-sle-associated-pulmonary-.... Accessed November 25, 2019.
  • M C Mizus, E Tiniakou. Lipid-lowering Therapies in Myositis. Curr Rheumatol Rep. 2020 Aug 26;22(10):70. doi: 10.1007/s11926-020-00942-3.